神经肽Y与心血管疾病的研究进展被引量：10

下载PDF

导出

摘要神经肽Y(neuropeptide Y,NPY)是由36个氨基酸构成的多肽,广泛存在于大脑、周围交感神经和肾上腺髓质,在心血管疾病发生、发展等方面有多种作用。NPY对血压有双向调节作用。在中枢神经系统,NPY抑制血压升高,外周NPY则增强血管平滑肌收缩,升高血压。NPY在动脉粥样硬化的进程中有利亦有弊。NPY还能调节水钠潴留,影响心肌和血管重塑。

作者雷静钟巧青 Robina Matyal 杨天伦

机构地区中南大学湘雅医院心内科湖南省郴州市第一人民医院心内科 Department of Anesthesia and Critical Care

出处《国际心血管病杂志》 2014年第5期311-314,共4页 International Journal of Cardiovascular Disease

关键词神经肽Y 心血管系统高血压冠心病心力衰竭

分类号 R54 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献29

1PonsJ,LeeEW,LiL,etal.NeuropeptideY:multiplereceptorsand multiplerolesincardiovasculardiseases[J].CurrOpinInvestigDrugs,2004,5(9):957-962.
2ZukowskaZ,PonsJ,LeeEW,etal.NeuropeptideY:anewmediator linking sympathetic nerves, blood vessels andimmunesystem?[J].CanJPhysiolPharmacol,2003,81(2):89-94.
3PedrazziniT,PralongF,Grouzmann E.Neuropeptide Y:theuniversalsoldier[J].Cell MolLifeSci,2003,60(2):350-377.
4WestfallTC.Neuropeptide Y andsympatheticcontrolofvasculartone in hypertension [J]. EXS,2006, (95):89-103.
5BhaskarLV,ThangarajK,NonAL,etal.NeuropeptideYgenefunctional polymorphism influences susceptibility tohypertensioninIndianpopulation[J].J Hum Hypertens,2010,24(9):617-622.
6WangL,RaoF,ZhangK,etal.NeuropeptideY(1)ReceptorNPY1R discovery of naturally occurring human geneticvariants governing gene expression in cella as well aspleiotropiceffectsonautonomicactivityandbloodpressureinvivo[J].JAm CollCardiol,2009,54(10):944-954.
7BaltatziM,HatzitoliosA,TziomalosK,etal.NeuropeptideYandalphamelanocytestimulatinghormone:interactioninobesityandpossibleroleinthedevelopmentofhypertension[J].IntJClinPract,2008,62(9):1432-1440.
8MorrisMJ,TortelliCF,HartDP,etal.Vascularandbrainneuropeptide Y in banded and spontaneously hypertensiverats[J].Peptides,2004,25(8):1313-1319.
9MichalkiewiczM,ZhaoG,JiaZ,etal.CentralneuropeptideYsignalingameliorates N(omega)nitroLarginine methylester hypertension in the rat through a Y1 receptormechanism[J].Hypertension,2005,45(4):780-785.
10RuohonenST,SavontausE,RinneP,etal.Stressinducedhypertension and increased sympathetic activity in miceoverexpressingneuropeptideYinnoradrenergicneurons[J].Neuroendocrinology,2009,89(3):351-360.

二级参考文献30

1Choi BJ, Prasad A, Gulati R, et al. Coronary endothelial dysfunction in patients with early coronary artery disease is associated with the increase in intravascular lipid core plaque[J] Eur Heart J, 2013, 34(27):2047-2054.
2Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis[J]. Circulation, 2004, 109 (23 Suppl 1): ]1127-1]]32.
3Mudau M, Genis A, Lochner A, et al. Endothelial dysfunction: the early predictor of atherosclerosis[J]. Cardiovasc J Aft, 2012, 23(4): 222-231.
4Muller M. Cellular senescence: molecular mechanisms, in vivosignificance, and redox considerations[J]. Antioxid Redox Signal, 2009, 11(1): 59-98.
5Minamino T, Komuro I. Vascular cell senescence: contribution to atherosclerosis[J]. Circ Res, 2007, 100(1): 15-26.
6Khaidakov M, Wang X, Mehta JL Potential involvement of LOX-1 in functional consequences of endothelial senescence [J]. PloSone, 2011, 6(6): e20964.
7Verdun RE, Karlseder J. Replication and protection of telomeres[J]. Nature, 2007, 447(7147): 924-931.
8Fyhrquist F, Saiionmaa O, Strandberg T. The roles of senescence and telomere shortening in cardiovascular disease [J]. Nat RevCardioI, 2013, 10(5): 274-283.
9Melchior B, Frangos JA. Distinctive subcellular Akt-1 responses to shear stress in endothelial cells[J]. J Cell Biochem, 2013, [Epub ahead of printS.
10Young EW, Simmons CA. Macro- and microscale fluid flow systems for endothelial cell biology[J]. Lab Chip, 2010, 10(2): 143-160.